Skip to content

Changes in Body Composition and Nutritional Status in Patients Undergoing Liver Transplantation

Changes in Body Composition and Nutritional Status Assessed by Bioelectrical Impedance Vector Analysis in Cirrhotic Patients Undergoing Liver Transplantation

Status
UNKNOWN
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT02023190
Enrollment
60
Registered
2013-12-30
Start date
2019-01-03
Completion date
2022-12-31
Last updated
2020-03-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Liver Cirrhosis

Keywords

liver cirrhosis, liver transplant, nutritional status, bioelectrical impedance vector analysis

Brief summary

Liver transplant is the goal treatment for every patient with end-stage chronic liver disease. Quality of life improves after transplant because the main complications of end-stage liver disease disappear, but due to immunosuppression other alterations appear such as metabolic alterations, weight gain, among others. Body composition and nutritional status can be affected do to post-transplant pharmacologic therapy.

Detailed description

Body composition and nutritional status can be affected due to post-transplant pharmacologic therapy. This is a prospective cohort study, patients from liver transplant waiting list will be assessed, pre and post-transplant measures of body composition and nutritional status will be obtained.

Interventions

None listed

Sponsors

Instituto Nacional de Ciencias Medicas y Nutricion Salvador Zubiran
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to 60 Years
Healthy volunteers
No

Inclusion criteria

* Liver cirrhosis (any etiology) * Enrolled in waiting list for tliver transplant

Exclusion criteria

* Hepatocellular carcinoma * Chronic renal failure * Congestive cardiac failure * Extremity amputation * Pregnancy

Design outcomes

Primary

MeasureTime frameDescription
Body compositionBaseline, 7 days, 1 month, 3 months and 6 months post-tranpslantBody composition will be assessed through bioelectrical impedance vector analysis graph.

Secondary

MeasureTime frame
Liver function testsBaseline, 7 days, 1 month, 3 months and 6 months post-tranpslant

Countries

Mexico

Contacts

Primary ContactAldo Torre, MD MSci
detoal@yahoo.com54870900
Backup ContactAstrid Ruiz-Margain, M.Sci
ruizm.astrid@gmail.com54870900

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026